Johanna Falkenhorst

7PUBLICATIONS
71CO-AUTHORS
Evolutionary ecologyMolecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2026
Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

|Feb 26, 2024
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.

Thomas Mühlenberg, Johanna Falkenhorst, Tom Schulz

|Oct 07, 2021
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study.

Bruno Vincenzi, Andrea Napolitano, Marta Fiocco

|Sep 21, 2021
Localized Angiosarcoma, Not One Disease: A Retrospective Single-Center Study on Prognosis Depending on the Primary Site and Etiology.

Inna Schott, Sven-Thorsten Liffers, Farhad Farzaliyev

|Sep 25, 2020
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain.

Susanne Grunewald, Lillian R Klug, Thomas Mühlenberg

Pageof 2

Frequent Collaborators

7 joint publications

Sebastian Bauer

4 joint publications

Thomas Mühlenberg

4 joint publications

Daniel Rauh

3 joint publications

Hans-Ulrich Schildhaus